SAN DIEGO, CA--(Marketwired - Feb 12, 2015) - Ivera Medical announced today that the United States Patent & Trademark Office (USPTO) has issued a Notice of Allowance for a new patent for its innovative Curos® disinfecting port protector technology. Issued on February 3, 2015, this new patent will be directed to Ivera's core technology for its Curos Port Protector and Curos Strip products.

"We are pleased with the allowance of this Track 1 patent, as it is another important piece of our patent portfolio," said Bob Rogers, CEO of Ivera Medical. "Curos continues to grow as a new standard in disinfection, and we are proud of the intellectual property that we created with the Curos Port Protector family of products."

"Curos products are helping hospitals manage their disinfection protocols, which in turn can help patients, as well as save hospitals significant money. This most recent patent is yet another example of our investment in, and commitment to protecting patient safety and reducing the cost of healthcare," said Mr. Rogers.

About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at www.curos.com.